BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Barts Cancer Institute - Queen Mary University of London - ECPv6.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bci.qmul.ac.uk
X-WR-CALDESC:Events for Barts Cancer Institute - Queen Mary University of London
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190328T123000
DTEND;TZID=Europe/London:20190328T133000
DTSTAMP:20260411T184714
CREATED:20190325T103544Z
LAST-MODIFIED:20190325T103544Z
UID:2984-1553776200-1553779800@www.bci.qmul.ac.uk
SUMMARY:Thursday Seminar Series - Dr Barrie Peck
DESCRIPTION:As part of the BCI’s Seminar Series\, we are pleased to welcome Dr Barrie Peck from The Institute of Cancer Research to present at the BCI on Thursday 28th March. For more information about Dr Peck’s research\, please read the biography below. \nThe seminar will be titled: ‘Modelling the tumour microenvironment to identify novel targets in cancer’ \nThe seminar will be held in the Lister and Young Seminar Room\, 12.30pm – 13.30pm. \nIf you would like to arrange to talk with Dr Peck\, please contact Denise Gardner (d.gardner@qmul.ac.uk). \n  \nBiography: \nDoctor Barrie Peck studied Molecular Biology and Genetics at Royal Holloway before moving to Imperial College London to complete a PhD in studying the role and regulation of forkhead transcription factors in breast cancer. After this\, he moved to the London Research Institute (now the Crick Institute) to the lab of Prof. Almut Schulze to study cancer metabolism. This work focussed on identifying novel cancer-specific dependencies in cancer metabolism. Indeed\, as part of the Lipid metabolism consortium\, they identified ACSS2 as a fundamental dependency of aggressive breast and prostate cancers. There are now significant efforts in developing small molecule inhibitors to target ACSS2 in cancer. \nDr. Peck then moved to the Institute of Cancer Research to the lab of Dr. Rachael Natrajan to identify novel tumour suppressors in breast cancer. At the ICR he has developed bespoke 3-dimensional screening pipelines and discovered novel genes that impact disease progression and response to targeted therapies. This work was recently awarded a BCN Catalyst grant in collaboration with Pfizer. \nDr. Peck has a keen interest in functional genomics\, cancer cell metabolism and the impact extrinsic factors\, such as diet\, can have on disease trajectory in cancer.
URL:https://www.bci.qmul.ac.uk/event/thursday-seminar-series-dr-barrie-peck/
LOCATION:Lister and Young Seminar Room\, John Vane Science Centre\, London\, EC1M 6BQ
CATEGORIES:BCI@CHSQ Seminars,Thursday Seminar Series
END:VEVENT
END:VCALENDAR